News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
217–252
Matches
328
Sources here
16
Companies here
10
Search results Stored financial headlines

Active search

328 matching headlines

Ticker or company: RAREMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

USA Rare Earth Names Serra Verde CEO as Barbara Humpton Steps Down

USA Rare Earth has named Serra Verde CEO Thras Moraitis as its next chief executive officer, signaling a leadership shift as the company moves toward completing its planned merger with the Brazilian rare earth producer and focuses on operational execution. Moraitis will assume the …

USAR main company USAR main company
Sharemaestro market context Price below Trend Line 44 weeks -39.9% USAR stored weekly price path from 17 Oct 2025 to 14 Aug 2026

Tactical Resources and Plum Acquisition Corp. III Announce Receipt of Nasdaq Approval; Transaction Expected to Close on July 28, 2026

Resulting Issuer to Trade on Nasdaq under Ticker Symbol "TREO" VANCOUVER, British Columbia, July 20, 2026--(BUSINESS WIRE)--Tactical Resources Corp. (TSXV:RARE) (OTC:USREF) ("Tactical" or the "Company"), a U.S.-focused rare earth elements development company, today announced that it has received an approval letter from the Nasdaq …

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RARE - burns cash despite four approved drugs, trapped by structural inefficiencies and gene-therapy scaling hurdles that thin safety margins.

Ultragenyx Pharmaceutical (RARE) is burning cash despite having four approved rare-disease drugs, due to structural inefficiencies and challenges in scaling gene-therapy manufacturing. The author argues that the company's commercial model is inefficient, its royalty streams are diluted, and current restructuring efforts are defensive rather …

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ultragenyx Pharmaceutical (RARE) On Rare Disease Growth Narrative And Why Valuation Is Back In Focus

Ultragenyx Pharmaceutical (RARE) stock is experiencing a valuation reassessment, with its rare disease portfolio and late-stage pipeline driving investor focus. While a narrative suggests the stock is 43.7% undervalued at $52.05 against its current $29.28 price, based on strong growth potential in rare disease …

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ultragenyx Pharmaceutical Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since December 2024 -- Data Talk

Ultragenyx Pharmaceutical (RARE) is experiencing its longest losing streak since December 2024, having been down for eight consecutive trading days. This represents a significant decline for the company, as indicated by its stock performance and comparison to past trends.

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RARE stock rises after Ultragenyx reports strong Crysvita revenue growth and narrows quarterly loss

Ultragenyx Pharmaceutical Inc. (RARE) stock saw a rise following reports of strong Crysvita revenue growth and a narrowed net loss in its latest quarterly update. Crysvita, a key therapy for rare metabolic bone conditions, has been a significant driver of the company's product revenue, …

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Mineral Resources and USA Rare Earth Merger Sparks Stockholder Lawsuits and Leads to Supplemental Disclosure

Texas Mineral Resources Corp. and USA Rare Earth, Inc. have issued supplemental disclosure materials after two stockholder lawsuits and multiple demand letters challenged their planned merger, announced on March 4, 2026. The new filings aim to provide additional information to stockholders, including prospective financial …

USAR main company
Sharemaestro market context Price below Trend Line 52 weeks +25.9% · Next-week setup positive 61.7% USAR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context